What does CUSIP 29664W105 represent in this 13F holders report?

CUSIP 29664W105 is the security identifier for ESPR - Esperion Therapeutics, Inc. - COM used to aggregate holder disclosures.

How many institutions held ESPR - Esperion Therapeutics, Inc. - COM in Q1 2020?

157 institutional investors reported ESPR - Esperion Therapeutics, Inc. - COM for Q1 2020. Use the holders table for investor-level position and value details.

Esperion Therapeutics, Inc. - COM (ESPR)

CUSIP: 29664W105

Q1 2020 13F Holders as of 31 Mar 2020

Type / Class: Equity / COM
Shares outstanding: 258,506,508
Total 13F shares: 29,570,957
Share change: +1,997,009
Total reported value: $916,082,618
Put/Call ratio: 154%
Price per share: $31.53
Number of holders: 157
Value change: +$53,953,340
Number of buys: 83
Number of sells: 84

Quarterly Holders Quick Answers

What is CUSIP 29664W105?
CUSIP 29664W105 identifies ESPR - Esperion Therapeutics, Inc. - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2020
Previous quarter: Q4 2019

Recent filing periods for CUSIP 29664W105:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ESPR - Esperion Therapeutics, Inc. - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Bellevue Group AG	13F	Company	1.8%	4,525,010	$269,826,000	—	31 Dec 2019	13F
VANGUARD GROUP INC	13F	Company	1%	2,647,911	$157,894,000	—	31 Dec 2019	13F
Pentwater Capital Management LP	13F	Company	0.87%	2,253,261	$134,362,000	—	31 Dec 2019	13F
BlackRock Finance, Inc.	13F	Company	0.8%	2,068,232	$123,329,000	—	31 Dec 2019	13F
Meditor Group Ltd	13F	Company	1%	2,679,835	$120,615,000	—	31 Dec 2019	13F
STATE STREET CORP	13F	Company	0.43%	1,101,509	$65,683,000	—	31 Dec 2019	13F
Boxer Capital, LLC	13F	Company	0.38%	975,000	$58,139,000	—	31 Dec 2019	13F
CREDIT SUISSE AG/	13F	Company	0.34%	887,741	$52,936,000	—	31 Dec 2019	13F
WASATCH ADVISORS LP	13F	Company	0.26%	664,707	$39,636,000	—	31 Dec 2019	13F
Rhenman & Partners Asset Management AB	13F	Company	0.26%	660,000	$39,356,000	—	31 Dec 2019	13F
NOMURA HOLDINGS INC	13F	Company	0.21%	550,000	$32,708,000	—	31 Dec 2019	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.16%	405,811	$24,198,000	—	31 Dec 2019	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.13%	346,076	$20,636,000	—	31 Dec 2019	13F
AMUNDI ASSET MANAGEMENT US, INC.	13F	Company	0.13%	326,798	$19,487,000	—	31 Dec 2019	13F
PINNACLE ASSOCIATES LTD	13F	Company	0.12%	315,889	$18,836,000	—	31 Dec 2019	13F
NORGES BANK	13F	Company	0.12%	313,569	$18,698,000	—	31 Dec 2019	13F
NORTHERN TRUST CORP	13F	Company	0.12%	310,362	$18,506,000	—	31 Dec 2019	13F
ROTHSCHILD & CO ASSET MANAGEMENT US INC.	13F	Company	0.11%	295,081	$17,596,000	—	31 Dec 2019	13F
Granahan Investment Management, LLC	13F	Company	0.11%	285,327	$17,014,000	—	31 Dec 2019	13F
Man Group plc	13F	Company	0.11%	282,996	$16,875,000	—	31 Dec 2019	13F
Hood River Capital Management LLC	13F	Company	0.1%	269,845	$16,091,000	—	31 Dec 2019	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.1%	258,151	$15,394,000	—	31 Dec 2019	13F
BALYASNY ASSET MANAGEMENT L.P.	13F	Company	0.1%	250,377	$14,930,000	—	31 Dec 2019	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.09%	221,952	$13,235,000	—	31 Dec 2019	13F
S.c.a. Candriam	13F	Individual	0.08%	215,096	$12,826,000	—	31 Dec 2019	13F
Tekla Capital Management LLC	13F	Company	0.08%	213,562	$12,735,000	—	31 Dec 2019	13F
FMR LLC	13F	Company	0.08%	205,864	$12,275,000	—	31 Dec 2019	13F
DEUTSCHE BANK AG\	13F	Company	0.08%	196,476	$11,714,000	—	31 Dec 2019	13F
HSBC HOLDINGS PLC	13F	Company	0.07%	192,711	$11,570,000	—	31 Dec 2019	13F
BAMCO INC /NY/	13F	Company	0.07%	188,500	$11,240,000	—	31 Dec 2019	13F
CITADEL ADVISORS LLC	13F	Company	0.06%	164,825	$9,829,000	—	31 Dec 2019	13F
Nuveen Asset Management, LLC	13F	Company	0.06%	163,976	$9,778,000	—	31 Dec 2019	13F
Bank of New York Mellon Corp	13F	Company	0.06%	152,752	$9,109,000	—	31 Dec 2019	13F
Avidity Partners Management LP	13F	Company	0.05%	130,400	$7,776,000	—	31 Dec 2019	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.05%	124,838	$7,444,000	—	31 Dec 2019	13F
MOODY ALDRICH PARTNERS LLC	13F	Company	0.05%	124,231	$7,408,000	—	31 Dec 2019	13F
BARCLAYS PLC	13F	Company	0.04%	108,013	$6,440,000	—	31 Dec 2019	13F
JPMORGAN CHASE & CO	13F	Company	0.04%	101,306	$6,042,000	—	31 Dec 2019	13F
BAILARD, INC.	13F	Company	0.03%	89,900	$5,361,000	—	31 Dec 2019	13F
GAM Holding AG	13F	Company	0.03%	88,000	$5,247,000	—	31 Dec 2019	13F
AXA S.A.	13F	Company	0.03%	82,260	$4,905,000	—	31 Dec 2019	13F
SEI INVESTMENTS CO	13F	Company	0.03%	80,452	$4,797,000	—	31 Dec 2019	13F
PDT Partners, LLC	13F	Company	0.03%	69,400	$4,138,000	—	31 Dec 2019	13F
Nicholas Investment Partners, LP	13F	Company	0.03%	68,570	$4,089,000	—	31 Dec 2019	13F
BNP PARIBAS FINANCIAL MARKETS	13F	Company	0.03%	67,426	$4,020,612	—	31 Dec 2019	13F
ClariVest Asset Management LLC	13F	Company	0.03%	66,235	$3,949,000	—	31 Dec 2019	13F
UBS Group AG	13F	Company	0.03%	64,965	$3,874,000	—	31 Dec 2019	13F
QS Investors, LLC	13F	Company	0.02%	62,150	$3,813,000	—	31 Dec 2019	13F
PICTET ASSET MANAGEMENT LTD	13F	Company	0.02%	61,708	$3,680,000	—	31 Dec 2019	13F
MORGAN STANLEY	13F	Company	0.02%	59,051	$3,522,000	—	31 Dec 2019	13F

Institutional Holders of Esperion Therapeutics, Inc. - COM (ESPR) as of Q1 2020

As of 31 Mar 2020, Esperion Therapeutics, Inc. - COM (ESPR) was held by 157 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 29,570,957 shares. The largest 10 holders included Bellevue Group AG, Meditor Group Ltd, VANGUARD GROUP INC, Pentwater Capital Management LP, BlackRock Inc., MARSHALL WACE, LLP, STATE STREET CORP, BOXER CAPITAL, LLC, WASATCH ADVISORS INC, and CREDIT SUISSE AG/. This page lists 157 institutional shareholders reporting positions in this security for the Q1 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2020 vs Q4 2019 Across Filers

Q4 2019 holders

170

Q1 2020 holders

157

Holder diff

-13

Investor	Q4 2019 Shares	Q1 2020 Shares	Share Diff	Share Chg %	Q4 2019 Value $	Q1 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.